AAAAAA

   
Results: 1-21 |
Results: 21

Authors: DACOSTA A TARDYPONCET B ISAAZ K CERISIER A MISMETTI P SIMITSIDIS S REYNAUD J TARDY B PIOT M DECOUSUS H GUYOTAT D
Citation: A. Dacosta et al., PREVALENCE OF FACTOR-V-LEIDEN (APCR) AND OTHER INHERITED THROMBOPHILIAS IN YOUNG-PATIENTS WITH MYOCARDIAL-INFARCTION AND NORMAL CORONARY-ARTERIES, HEART, 80(4), 1998, pp. 338-340

Authors: MISMETTI P REYNAUD J LAPORTESIMITSIDIS S THIJSSEN H TARDYPONCET B TARDY B BUCHMULLER A DECOUSUS H
Citation: P. Mismetti et al., PHARMACOKINETIC AND PHARMACODYNAMIC VARIATIONS OF ACENOCOUMAROL ORALLY ADMINISTRATED EITHER ONCE OR TWICE-DAILY IN PATIENTS WITH DEEP VENOUS THROMBOSIS, Fundamental and clinical pharmacology, 12(6), 1998, pp. 631-635

Authors: TARDY B TARDYPONCET B VIALLON A PIOT M MAZET E
Citation: B. Tardy et al., FATAL DANAPAROID-SODIUM INDUCED THROMBOCYTOPENIA AND ARTERIAL THROMBOSES, Thrombosis and haemostasis, 80(3), 1998, pp. 530-530

Authors: TARDY B TARDYPONCET B VIALLON A LAFOND P PAGE V VENET C BERTRAND JC
Citation: B. Tardy et al., EVALUATION OF D-DIMER ELISA TEST IN ELDERLY PATIENTS WITH SUSPECTED PULMONARY-EMBOLISM, Thrombosis and haemostasis, 79(1), 1998, pp. 38-41

Authors: TARDY B TARDYPONCET B VIALLON A LAFOND P PAGE Y BERTRAND JC
Citation: B. Tardy et al., UNUSEFULNESS OF D-DIMER ELISA TESTS IN ELDERLY PATIENTS WITH SUSPECTED PULMONARY-EMBOLISM, Thrombosis and haemostasis, 1997, pp. 167-167

Authors: DACOSTA A TARDYPONCET B ISAAZ K CERISIER A MISMETTI P SIMITSIDIS S RAYNAUD J TARDY B DECOUSUS H GUYOTAT D
Citation: A. Dacosta et al., PREVALENCE OF FACTOR-V-LEIDEN AND OF OTHER INHERITED THROMBOPHILIA INYOUNG-PATIENTS UNDER 45 YEARS WITH MYOCARDIAL-INFARCTION AND NORMAL CORONARY-ARTERIES - A PROSPECTIVE-STUDY, Thrombosis and haemostasis, 1997, pp. 1280-1280

Authors: DACOSTA A TARDYPONCET B ISAAZ K CERISIER A MISMETTI P SIMITSIDIS S REYNAUD J BACHONGY P DECOUSUS H GUYOTAT D
Citation: A. Dacosta et al., FACTOR-V-LEIDEN AND ACUTE MYOCARDIAL-INFARCTION WITH NORMAL CORONARY-ARTERIES - A CASE-CONTROL STUDY, Thrombosis and haemostasis, 1997, pp. 1284-1284

Authors: TARDYPONCET B
Citation: B. Tardyponcet, FRENCH EXPERIENCE IN THE USE OF ORGARAN AS AN ALTERNATIVE ANTITHROMBOTIC TREATMENT FOR PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA, Thrombosis and haemostasis, 1997, pp. 1825-1825

Authors: TARDY B TARDYPONCET B LAPORTESIMITSIDIS S MISMETTI P DECOUSUS H GUYOTAT D BERTRAND JC
Citation: B. Tardy et al., EVOLUTION OF BLOOD-COAGULATION AND FIBRINOLYSIS PARAMETERS AFTER ABRUPT VERSUS GRADUAL WITHDRAWAL OF ACENOCOUMAROL IN PATIENTS WITH VENOUS THROMBOEMBOLISM - A DOUBLE-BLIND RANDOMIZED STUDY, British Journal of Haematology, 96(1), 1997, pp. 174-178

Authors: TARDYPONCET B REYNAUD J TARDY B MAHUL P MISMETTI P BERAUD AM REBAUD MA BAYON M GUYOTAT D
Citation: B. Tardyponcet et al., ORG-10172 FOR HEPARIN-INDUCED THROMBOCYTO PENIA - TOLERANCE AND EFFICACY, La Presse medicale, 25(16), 1996, pp. 751-755

Authors: TARDY B TARDYPONCET B BARA L LAPORTESIMITSIDIS S RASCLE F SAMAMA MM GUYOTAT D BERTRAND JC
Citation: B. Tardy et al., EFFECTS OF LONG TRAVELS IN SITTING POSITION IN ELDERLY VOLUNTEERS ON BIOLOGICAL - MARKERS OF COAGULATION ACTIVATION AND FIBRINOLYSIS, Thrombosis research, 83(2), 1996, pp. 153-160

Authors: GIRARD P TARDY B PAGE Y MOSNIER JF TARDYPONCET B BERTRAND JC
Citation: P. Girard et al., CANCER PRESENTING AS THROMBOTIC THROMBOCT YOPENIC PURPURA - 2 CASE-REPORTS, La Presse medicale, 24(3), 1995, pp. 175-178

Authors: MISMETTI P REYNAUD J TARDYPONCET B LAPORTESIMITSIDIS S SCULLY M GOODWYN C QUENEAU P DECOUSUS H
Citation: P. Mismetti et al., CHRONO-PHARMACOLOGICAL STUDY OF ONCE-DAILY CURATIVE DOSE OF A LOW-MOLECULAR-WEIGHT HEPARIN (200 IU ANTIXA KG OF DALTEPARIN) IN 10 HEALTHY-VOLUNTEERS/, Thrombosis and haemostasis, 74(2), 1995, pp. 660-666

Authors: TARDY B TARDYPONCET B SIMITSIDIS S DECOUSUS H MISMETTI P LEIZOROVICZ A BERTRAND JC GUYOTAT D
Citation: B. Tardy et al., ABRUPT VERSUS GRADUAL WITHDRAWAL OF ACENOCOUMAROL IN VENOUS THROMBOEMBOLIC DISEASE - A DOUBLE-BLIND RANDOMIZED STUDY, Thrombosis and haemostasis, 73(6), 1995, pp. 1119-1119

Authors: TARDYPONCET B REYNAUD J TARDY B MAHUL P MISMETTI P DECOUSUS H GUYOTAT D
Citation: B. Tardyponcet et al., EFFICACY AND SAFETY OF ORGARAN ANTICOAGULATION IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA, Thrombosis and haemostasis, 73(6), 1995, pp. 1323-1323

Authors: TARDYPONCET B MAHUL P BERAUD AM FAVRE JP TARDY B GUYOTAT D
Citation: B. Tardyponcet et al., FAILURE OF ORGARAN THERAPY IN A PATIENT WITH A PREVIOUS HEPARIN-INDUCED THROMBOCYTOPENIA SYNDROME, British Journal of Haematology, 90(4), 1995, pp. 969-970

Authors: CONCHONNET P MISMETTI P REYNAUD J LAPORTESIMITSIDIS S TARDYPONCET B BOISSIER C RAMBAUD C DECOUSUS H
Citation: P. Conchonnet et al., FIBRINOLYSIS AND ELASTIC COMPRESSION - NO FIBRINOLYTIC EFFECT OF ELASTIC COMPRESSION IN HEALTHY-VOLUNTEERS, Blood coagulation & fibrinolysis, 5(6), 1994, pp. 949-953

Authors: TARDYPONCET B TARDY B GRELAC F REYNAUD J MISMETTI P BERTRAND JC GUYOTAT D
Citation: B. Tardyponcet et al., PENTOSAN POLYSULFATE-INDUCED THROMBOCYTOPENIA AND THROMBOSIS, American journal of hematology, 45(3), 1994, pp. 252-257

Authors: TARDY B TARDYPONCET B REYNAUD J LAPORTESIMITSIDIS S BORDET JC PAGE Y DECOUSUS H GUYOTAT D BERTRAND JC
Citation: B. Tardy et al., EVOLUTION OF BIOLOGICAL MARKERS OF HEMOSTATIC ACTIVATION AFTER A LONGTRAVEL IN SITTING POSITION IN ELDER VOLUNTEERS, Thrombosis and haemostasis, 69(6), 1993, pp. 629-629

Authors: TARDYPONCET B REYNAUD J RICHARD O LAPORTESIMITSIDIS S GOUNOT R GUYOTAT D
Citation: B. Tardyponcet et al., WHAT ARE THE NORMAL VALUES OF THE COAGULATION INHIBITORS IN CHILDREN, Thrombosis and haemostasis, 69(6), 1993, pp. 901-901

Authors: TARDY B TARDYPONCET B PAGE Y DECOUSUS H GUYOTAT D BERTRAND JC
Citation: B. Tardy et al., LOW-MOLECULAR-WEIGHT HEPARIN FOR HICKMAN CATHETER-INDUCED THROMBOSIS IN THROMBOCYTOPENIC PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION, Cancer, 71(9), 1993, pp. 2882-2883
Risultati: 1-21 |